Mounjaro vs Ozempic — Which One Works Better? cover art

Mounjaro vs Ozempic — Which One Works Better?

Mounjaro vs Ozempic — Which One Works Better?

Written by: Inception Point Ai
Listen for free

About this listen

 Dr. Ben Synth unpacks the SURMOUNT-5 trial results comparing tirzepatide and semaglutide head-to-head in the largest obesity drug study ever conducted. Discover what 751 patients taught us about weight loss efficacy, cardiovascular benefits, and real-world tolerability differences that are reshaping clinical practice.

For more content like this, visit QuietPlease.aiCopyright 2025 Inception Point Ai Hygiene & Healthy Living Physical Illness & Disease
Episodes
  • Mounjaro vs Ozempic — Which One Works Better? - Weigh the evidence with Dr. Ben Synth

    Mounjaro vs Ozempic — Which One Works Better? - Weigh the evidence with Dr. Ben Synth
    Apr 7 2026
    Join Dr. Ben Synth as he breaks down the ultimate weight loss showdown: Mounjaro versus Ozempic. Discover which GLP-1 medication delivers superior results, from dramatic weight loss differences to cardiovascular benefits and side effects your doctor should discuss. Get the unfiltered science behind obesity medicine's biggest breakthrough drugs.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Show More Show Less
    1 min
  • Mounjaro vs Ozempic — Which One Works Better? - Side Effects, Dropouts & Tolerability

    Mounjaro vs Ozempic — Which One Works Better? - Side Effects, Dropouts & Tolerability
    Apr 7 2026
    Join Ben Synth as he unpacks the SURMOUNT-5 trial's surprising tolerability data comparing Mounjaro (tirzepatide) to Ozempic (semaglutide). Discover why fewer patients quit the higher-dose medication, what quality-of-life metrics reveal beyond weight loss, and why adherence matters more than any number on the scale for long-term obesity treatment success.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Show More Show Less
    29 mins
  • Mounjaro vs Ozempic — Which One Works Better? - Beyond the Scale: The Hidden Data

    Mounjaro vs Ozempic — Which One Works Better? - Beyond the Scale: The Hidden Data
    Apr 7 2026
    Host Ben Synth examines the SURMOUNT-5 trial's overlooked findings beyond weight loss: tirzepatide versus semaglutide's impact on cardiovascular risk, quality of life, and long-term health outcomes. We discuss post-hoc analysis published in the European Heart Journal Open suggesting potential population-level differences in predicted heart attack and stroke prevention between these obesity medications.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Show More Show Less
    20 mins
No reviews yet